Global Biopharmaceutical Leader to Usher C-Path in Next Phase of Growth and Innovation

Retrieved on: 2022-09-28 02:48:41

Tags for this article:

Click the tags to see associated articles and topics

Global Biopharmaceutical Leader to Usher C-Path in Next Phase of Growth and Innovation. View article details on hiswai:

Excerpt

PRNewswire/ -- Critical Path Institute (C-Path) today named Daniel M. Jorgensen, M.D., MPH, MBA, its Chief Executive Officer (CEO).

Article found on: www.prnewswire.com